Visunex Medical Systems Inc

Healthcare Design Solutions Inc. (HDS), established in November 2004, specializes in providing quality medical equipment and comprehensive support for healthcare facility projects. With a focus on new construction and facility updates, HDS aims to help clients stay competitive while ensuring effective patient care. By leveraging extensive project experience and product knowledge, HDS meets the high demand for skilled professionals in the design development stages, catering to architects, engineers, and construction managers. The company prides itself on offering cost-effective solutions to deliver projects on or under budget. Generated from the website

Thoratec Corporation is engaged in the research, development, manufacturing and marketing of medical devices for circulatory support, vascular graft, coagulation and incision applications. The company s ventricular assist device is approved for heart support and can be used as a bridge-to-transplant solution and for recovery from open-heart surgery. It has distributed more than 4,300 VADs for the treatment of 2,800-plus patients worldwide. Thoratec Corporation also develops implantable VADs. The company s HeartMate device assumes the pumping function of the left ventricle for patients with hearts that are too damaged or diseased to produce adequate blood flow. Its Vectra product is employed in hemodialysis patients. Thoratec s primary subsidiary, International Technidyne Corporation, provides point-of-care testing instruments and disposables. Thoratec Corporation is headquartered in Pleasanton, Calif.

Roche Diagnostics Operations Inc, based in Pleasanton, CA, is a part of the renowned Roche Group, dedicated to advancing healthcare through innovative solutions. Their focus spans both pharmaceutical and diagnostic solutions, aiming to improve patient outcomes globally. Driven by a commitment to improving people's quality of life, Roche Diagnostics Operations Inc prioritizes early disease detection, accurate diagnosis, and personalized treatment strategies. Their recent breakthroughs, like the FDA approval of Susvimo for diabetic macular edema, highlight their dedication to pioneering advancements in healthcare. Generated from the website content